// App-Quantinova.ai

P547 : CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA TREATED WITH VENETOCLAX COMBINATION THERAPY: REAL-WORLD EXPERIENCE IN BOTH FRONTLINE AND RELAPSED/REFRACTORY SETTINGS

Researchers

Presenter

  • Ho Pui Jeff Lam

Principal Investigators

  • Zoe Kirkham

  • Andrew Wilson

  • Richard Burt

  • Robert Sellar

  • Adele Fielding

  • Rajeev Gupta

  • Elspeth Payne

  • Marc Mansour

  • Panagiotis Kottaridis

  • Asim Khwaja

  • Jenny O'Nions

Medical Centers

  • Department of Haematology,University College London Hospitals NHS Foundation Trust,London,Regno Unito

  • Hematology,University College London Hospitals,London,Royaume-uni

  • Dept. Haematology,University College London Hospitals,London,Vereinigtes Königreich

  • Department of Haematology,University College London Hospitals NHS Foundation Trust,London,Regno Unito

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Hormone receptor

Drug/Treatment

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved